Surgical Robotics

Surgical robotics is one of the most commercially successful categories in medical technology, with Intuitive Surgical commanding nearly 60% of the global market and generating $8.4 billion in 2024 revenue, a 17% year-over-year increase. The sector has moved well beyond the question of whether robotic surgery works into a battle for specialization, accessibility, and the next generation of AI-assisted surgical capabilities.

Intuitive's da Vinci system, with 9,000+ installed systems globally, established the category through minimally invasive general surgery (prostatectomy was the killer app). The da Vinci 5, launched in 2025 with force feedback that reduces tissue trauma by 43%, represents the latest evolution. But the competitive landscape has shifted dramatically: Stryker's Mako system dominates orthopedic robotics (joint replacement), Medtronic's Hugo system entered general surgery, and Johnson & Johnson's Ottava platform is in development. Beyond the majors, a new generation of specialty surgical robots targets procedures that the da Vinci wasn't designed for: cataract surgery (ForSight Robots, $125 million in funding), spinal surgery (Globus Medical, Mazor), dental implants (Neocis), and microsurgery (Microsure).

The global surgical robots market is projected to reach $27 billion by 2030 from $14 billion in 2025, growing at 15% CAGR. The growth drivers are expanding surgical specialties, AI-powered surgical planning that improves outcomes, declining system costs making robotic surgery accessible to more hospitals, and ambulatory surgery center (ASC) adoption as procedures move from hospitals to outpatient settings. The top seven surgical robotics companies that disclosed fundraising have collectively raised over $2 billion, demonstrating sustained investor conviction.

For founders, the surgical robotics landscape in 2026 offers clear implications. Competing directly with Intuitive in general surgery is futile without billions in capital and a decade of development. The viable opportunities are in specific surgical specialties where the da Vinci doesn't serve well (ophthalmology, dental, micro/nanosurgery), AI-powered surgical planning and navigation that enhances any robotic platform, surgical training simulation and credentialing technology, data analytics from robotic surgical procedures, and disposable instruments and accessories that generate recurring revenue from the installed base of robotic systems.